Subscribe to Newsletter

Oncology

Subspecialties Precision medicine

CEA: Overlooked and Underused

| Roisin McGuigan

Could an existing blood test improve treatment choices – and outcomes – in colon cancer?

Diagnostics Histology

Case of the Month

What is the most likely diagnosis for this lung tumor removed from a 50-year-old man?

Outside the Lab Oncology

Kallikrein Dream

| Roisin McGuigan

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.

Outside the Lab Oncology

Battling Blood Cancer

| Michael Schubert

The FDA authorizes a new test for blood cancers, and establishes “special controls” for future tests

Diagnostics Biochemistry and molecular biology

The Testing Trinity

| Michael Schubert

A blood test that can predict treatment response and reveal evolving resistance in prostate cancer

Diagnostics Oncology

Methyl Markers

| Michael Schubert

Epigenetics may predict the risk of developing anal cancer

Diagnostics Cytology

Slides, Sections and Cells

The most beautiful, informative and intriguing images of pathology and laboratory medicine

Inside the Lab Liquid biopsy

Liquid Assets

| Roisin McGuigan

Two experts explain why they believe ctDNA analysis is the future of cancer pathology

Diagnostics Profession

Cracking Cancer’s Code

| Roisin McGuigan

George Calin, Professor, Department of Experimental Therapeutics, and Co-Director, The Center for RNA Interference and Non-coding RNAs, MD Anderson Cancer Center, USA

Diagnostics Omics

Embracing the Proteogenomic Toolkit

| Andreas Hühmer

To win the war on cancer, we need to put proteomics on an equal footing with genomics

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register